20 Jul Restem Group
Posted at 21:10h
in
Andres Isaias, CEO and Chairman
Oct. 5 | 5:30pm | FLW Ballroom F
Miami, FL
(Private)
Restem is a clinical-stage biotechnology company focused on the development of next-generation, off-the-shelf cell therapies designed to modulate the immune system and address autoimmune, inflammatory, and age-related diseases.